Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Influenza A virus infection induces liver injury in mice.

Zhang S, Hu B, Xu J, Ren Q, Wang L, Wang S.

Microb Pathog. 2019 Sep 7;137:103736. doi: 10.1016/j.micpath.2019.103736. [Epub ahead of print]

PMID:
31505263
2.

The PanVax Tool to Improve Pandemic Influenza Emergency Vaccination Program Readiness and Partnership.

Carias C, Lehnert JD, Greening B Jr, Adhikari BB, Kahn EB, Meltzer MI, Graitcer SB.

Am J Public Health. 2019 Sep;109(S4):S322-S324. doi: 10.2105/AJPH.2019.305233.

3.

Acute Encephalitis Syndrome with an Unusual Diagnosis.

Thomas M, Swarnam K, Remadevi GS, Pillai AM.

J Trop Pediatr. 2019 Aug 25. pii: fmz058. doi: 10.1093/tropej/fmz058. [Epub ahead of print]

PMID:
31504992
4.

Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study.

Hudson M, Dell'Aniello S, Shen S, Simon TA, Ernst P, Suissa S.

Rheumatology (Oxford). 2019 Sep 3. pii: kez359. doi: 10.1093/rheumatology/kez359. [Epub ahead of print]

PMID:
31504972
5.

Repeated Seasonal Influenza Vaccination-How Much is Too Much of a Good Thing?

Stacey HD, Miller MS.

J Infect Dis. 2019 Aug 26. pii: jiz434. doi: 10.1093/infdis/jiz434. [Epub ahead of print] No abstract available.

PMID:
31504654
6.

Evidence that blunted CD4 T cells responses underlie deficient protective antibody responses to influenza vaccines in repeatedly vaccinated human subjects.

Richards KA, Shannon I, Treanor JJ, Yang H, Nayak JL, Sant AJ.

J Infect Dis. 2019 Aug 26. pii: jiz433. doi: 10.1093/infdis/jiz433. [Epub ahead of print]

PMID:
31504634
7.

Is It Time For High Dose Influenza Vaccination In Inflammatory Bowel Diseases?

Syal G, Melmed GY.

Inflamm Bowel Dis. 2019 Aug 24. pii: izz165. doi: 10.1093/ibd/izz165. [Epub ahead of print] No abstract available.

PMID:
31504529
8.

Immunogenicity of High Dose Influenza Vaccine for Patients with Inflammatory Bowel Disease on Anti-TNF Monotherapy: A Randomized Clinical Trial.

Caldera F, Hillman L, Saha S, Wald A, Grimes I, Zhang Y, Sharpe AR, Reichelderfer M, Hayney MS.

Inflamm Bowel Dis. 2019 Aug 24. pii: izz164. doi: 10.1093/ibd/izz164. [Epub ahead of print]

PMID:
31504526
9.

High Risk of Influenza Virus Infection Among Swine Workers: Examining a Dynamic Cohort in China.

Borkenhagen LK, Wang GL, Simmons RA, Bi ZQ, Lu B, Wang XJ, Wang CX, Chen SH, Song SX, Li M, Zhao T, Wu MN, Park LP, Cao WC, Ma MJ, Gray GC.

Clin Infect Dis. 2019 Sep 1. pii: ciz865. doi: 10.1093/cid/ciz865. [Epub ahead of print]

PMID:
31504322
10.

Mutations in the H7 HA and PB1 genes of avian influenza a viruses increase viral pathogenicity and contact transmission in guinea pigs.

Dreier C, Resa-Infante P, Thiele S, Stanelle-Bertram S, Walendy-Gnirß K, Speiseder T, Preuss A, Müller Z, Klenk HD, Stech J, Gabriel G.

Emerg Microbes Infect. 2019;8(1):1324-1336. doi: 10.1080/22221751.2019.1663131.

PMID:
31503518
11.

Why are vaccines against many human viral diseases still unavailable; an historic perspective?

Tannock GA, Kim H, Xue L.

J Med Virol. 2019 Sep 10. doi: 10.1002/jmv.25593. [Epub ahead of print] Review.

PMID:
31502669
12.

Development times and approval success rates for drugs to treat infectious diseases.

DiMasi JA, Florez MI, Stergiopoulos S, Peña Y, Smith Z, Wilkinson M, Getz KA.

Clin Pharmacol Ther. 2019 Sep 10. doi: 10.1002/cpt.1627. [Epub ahead of print]

PMID:
31502248
13.

Determinants of Influenza Mortality Trends: Age-Period-Cohort Analysis of Influenza Mortality in the United States, 1959-2016.

Acosta E, Hallman SA, Dillon LY, Ouellette N, Bourbeau R, Herring DA, Inwood K, Earn DJD, Madrenas J, Miller MS, Gagnon A.

Demography. 2019 Sep 9. doi: 10.1007/s13524-019-00809-y. [Epub ahead of print]

PMID:
31502229
14.

Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study.

Nikiphorou E, de Lusignan S, Mallen C, Khavandi K, Roberts J, Buckley CD, Galloway J, Raza K.

Rheumatology (Oxford). 2019 Sep 9. pii: kez344. doi: 10.1093/rheumatology/kez344. [Epub ahead of print]

PMID:
31501866
15.
16.

IgM, IgG, and IgA Influenza-Specific Plasma Cells Express Divergent Transcriptomes.

Price MJ, Hicks SL, Bradley JE, Randall TD, Boss JM, Scharer CD.

J Immunol. 2019 Sep 9. pii: ji1900285. doi: 10.4049/jimmunol.1900285. [Epub ahead of print]

PMID:
31501259
17.

Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.

Nakamura K, Harada Y, Takahashi H, Trusheim H, Bernhard R, Hamamoto I, Hirata-Saito A, Ogane T, Mizuta K, Konomi N, Konomi Y, Asanuma H, Odagiri T, Tashiro M, Yamamoto N.

Vaccine. 2019 Sep 6. pii: S0264-410X(19)31140-5. doi: 10.1016/j.vaccine.2019.08.064. [Epub ahead of print]

18.

Factors and considerations for establishing and improving seasonal influenza vaccination of health workers: Report from a WHO meeting, January 16-17, Berlin, Germany.

Cherian T, Morales KF, Mantel C, Lambach P; Independent Expert Advisory Group (IEAG) for Health Worker Influenza Vaccination.

Vaccine. 2019 Sep 6. pii: S0264-410X(19)31000-X. doi: 10.1016/j.vaccine.2019.07.079. [Epub ahead of print]

PMID:
31500965
19.

Novel avian metaavulavirus isolated from birds of the family Columbidae in Taiwan.

Liu YP, Kuo ST, Chiou CJ, Terregino C, Tsai HJ.

Vet Microbiol. 2019 Sep;236:108377. doi: 10.1016/j.vetmic.2019.07.029. Epub 2019 Aug 1.

PMID:
31500723
20.

Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine.

Ghaffari H, Tavakoli A, Moradi A, Tabarraei A, Bokharaei-Salim F, Zahmatkeshan M, Farahmand M, Javanmard D, Kiani SJ, Esghaei M, Pirhajati-Mahabadi V, Ataei-Pirkooh A, Monavari SH.

J Biomed Sci. 2019 Sep 10;26(1):70. doi: 10.1186/s12929-019-0563-4.

Supplemental Content

Loading ...
Support Center